4.8 Article

Tryptophan Biosynthesis Protects Mycobacteria from CD4 T-Cell-Mediated Killing

Journal

CELL
Volume 155, Issue 6, Pages 1296-1308

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2013.10.045

Keywords

-

Funding

  1. National Institutes of Health [T32 GM007753, R01 AI 098637, P01 AI095208]
  2. Herchel Smith Graduate Fellowship of Harvard
  3. Wolfe-Welch Chair
  4. Cambridge University

Ask authors/readers for more resources

Bacteria that cause disease rely on their ability to counteract and overcome host defenses. Here, we present a genome-scale study of Mycobacterium tuberculosis (Mtb) that uncovers the bacterial determinants of surviving host immunity, sets of genes we term counteractomes. Through this analysis, we found that CD4 T cells attempt to contain Mtb growth by starving it of tryptophan-a mechanism that successfully limits infections by Chlamydia and Leishmania, natural tryptophan auxotrophs. Mtb, however, can synthesize tryptophan under stress conditions, and thus, starvation fails as an Mtb-killing mechanism. We then identify a small-molecule inhibitor of Mtb tryptophan synthesis, which converts Mtb into a tryptophan auxotroph and restores the efficacy of a failed host defense. Together, our findings demonstrate that the Mtb immune counteractomes serve as probes of host immunity, uncovering immune-mediated stresses that can be leveraged for therapeutic discovery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available